Home
About
Overview
Sharing Data
ORCID
Help
History (49)
Emergency Medicaid enrollment after traumatic injury predicts long-term health care utilization.
Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.
Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events: A 1-Year Follow-up.
Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
See All 49 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med. 2015 Jul 09; 373(2):123-35.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Antineoplastic Agents
B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Female
Humans
Immunoglobulin G
Lung Neoplasms
Male
Middle Aged
Programmed Cell Death 1 Receptor
Survival Analysis
Taxoids
authors with profiles
Marina Chiara Garassino
Everett Vokes